fluconazole has been researched along with 8,11,14-eicosatrienoic acid in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cracowski, C; Cracowski, JL; Gaillard-Bigot, F; Millet, C; Roustit, M; Sors, C | 1 |
| Best, WJ; Dias, DA; Dusting, GJ; Jayasinghe, NS; Jenkins, AJ; Lamoureux, EL; Man, RE; Nguyen, TT; Noonan, JE; Roessner, U | 1 |
| Ament, Z; Cheriyan, J; Griffin, JL; Gutterman, DD; Lazaar, AL; Mayer, RJ; Newby, DE; Tal-Singer, R; Wilkinson, IB; Yang, L | 1 |
3 trial(s) available for fluconazole and 8,11,14-eicosatrienoic acid
| Article | Year |
|---|---|
Involvement of cytochrome epoxygenase metabolites in cutaneous postocclusive hyperemia in humans.
Topics: 8,11,14-Eicosatrienoic Acid; Adult; Cytochrome P-450 CYP2J2; Cytochrome P-450 Enzyme System; Female; Fluconazole; Humans; Hyperemia; Lidocaine; Male; NG-Nitroarginine Methyl Ester; Nitroprusside; Regional Blood Flow; Sensory Receptor Cells; Skin; Skin Diseases | 2013 |
Flicker light-induced retinal vasodilation is unaffected by inhibition of epoxyeicosatrienoic acids and prostaglandins in humans.
Topics: 8,11,14-Eicosatrienoic Acid; Administration, Oral; Cross-Over Studies; Cytochrome P-450 CYP2C9 Inhibitors; Fluconazole; Humans; Light; Photic Stimulation; Prostaglandins; Reference Values; Retinal Vessels; Vasodilation | 2014 |
Mechanisms of Vascular Dysfunction in COPD and Effects of a Novel Soluble Epoxide Hydrolase Inhibitor in Smokers.
Topics: 8,11,14-Eicosatrienoic Acid; Adult; Aged; Blood Vessels; Bradykinin; Case-Control Studies; Cyclohexylamines; Endothelium, Vascular; Epoxide Hydrolases; Fluconazole; Forearm; Humans; In Vitro Techniques; Male; Middle Aged; Overweight; Plethysmography; Pulmonary Disease, Chronic Obstructive; Smoking; Triazines; Vasodilation; Vasodilator Agents | 2017 |